Update on the prevention and control of community-acquired meticillin-resistant Staphylococcus aureus (CA-MRSA)

Area of Science:

• Infectious Diseases
• Microbiology
• Public Health

Background:

• Community-acquired methicillin-resistant Staphylococcus aureus (CA-MRSA) has rapidly disseminated since the early 2000s, posing a significant public health concern.
• CA-MRSA infections present a varied global burden, with skin and soft-tissue infections being the most common manifestation, particularly in young, healthy individuals.
• While CA-MRSA strains exhibit varying antibiotic susceptibilities, they are often more susceptible to traditional antibiotics compared to hospital-acquired strains.

Purpose of the Study:

• To review and appraise the current evidence on the prevention and control strategies for CA-MRSA.
• To highlight the challenges in estimating the total disease burden due to regional and demographic variations.

Main Methods:

• Comprehensive literature review and evidence appraisal.
• Synthesis of current data on CA-MRSA epidemiology, clinical manifestations, and antibiotic susceptibility.
• Analysis of multifaceted prevention and control approaches.

Main Results:

• Skin and soft-tissue infections are the predominant clinical presentation of CA-MRSA.
• Antibiotic susceptibility patterns of CA-MRSA differ from hospital-acquired strains.
• Effective control necessitates a combination of screening, decolonization, hygiene, antibiotic stewardship, and future vaccination strategies.

Conclusions:

• Preventing CA-MRSA dissemination requires a coordinated, multifaceted public health approach.
• Continued research and implementation of evidence-based strategies are crucial for managing CA-MRSA.
• Vaccination holds future promise for CA-MRSA prevention.